Navigation Links
Herceptin May Boost Long-Term Survival After Aggressive Breast Cancer
Date:2/25/2011

By Maureen Salamon
HealthDay Reporter

THURSDAY, Feb. 24 (HealthDay News) -- The cancer drug Herceptin produces significantly longer disease-free survival in women with an aggressive type of early-stage breast cancer who take the drug for a year after standard chemotherapy, a new study suggests.

After analyzing more than 5,000 women from 39 countries between December 2001 and June 2005, Herceptin appeared to reduce the likelihood of a cancer recurrence by 24 percent, the Italian researchers said.

Herceptin (trastuzumab) is a monoclonal antibody that suppresses the HER2/neu protein, which fuels 20 percent to 30 percent of breast cancers. These so-called HER2-positive cancers tend to be aggressive and fast-growing.

"We were inclined to consider the possibility that long-term exposure to trastuzumab deserved a proper test and might be useful," said study author Dr. Luca Gianni, a researcher at Fondazione San Raffaele in Milan.

But while Herceptin patients in the four-year study experienced longer disease-free survival times than patients in an observation group taking chemotherapy alone, the overall risk of death was similar between the two groups.

Gianni attributed this to the fact that 52 percent of patients from the observation group crossed over to receive Herceptin treatment midway through the research because of the drug's impressive early results.

The study received funding from Hoffman-La Roche, the maker of Herceptin, and is published in the Feb. 25 issue of The Lancet Oncology.

"It is very difficult to account for the bias introduced by the late introduction of trastuzumab in more than half of the patients originally randomized to no therapy," Gianni said. "However, it is reasonable to think that the lack of a measurable improvement of survival in the current analysis was due to the effect of the introduction of trastuzumab therapy in a large proportion of women who selecte
'/>"/>

Copyright©2010 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. Herceptin and Tykerb effective against a subset of gastric cancers
2. Roche/Genentech/Chugais Herceptin as an Add-On to Standard Chemotherapy Will Become Decision Resources Clinical Gold Standard in 2013 for the Treatment Of Gastric Cancer
3. MiRNA-21 linked to tumor suppressor loss, herceptin resistance
4. Drug now used to treat erectile dysfuncton may enhance delivery of herceptin to certain brain tumors
5. Erythropoietin counteracts breast cancer treatment with herceptin
6. Global Nutrition Firm Takes Dose of SonicWALL to Boost Network Health
7. Aspirin May Boost Breast Cancer Survival
8. A midday nap markedly boosts the brains learning capacity
9. CustomerCentric Selling Helps BCC Software Dramatically Boost Sales Performance and Produce Record Results
10. Dry Weather Boosts Odds of Flu Outbreaks
11. Fitness Boosts Brain Power in Multiple Sclerosis Patients
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Herceptin May Boost Long-Term Survival After Aggressive Breast Cancer
(Date:10/22/2014)... -- The United States is now mandating that ... West Africa land at one of five airports ... virus. In a statement released Tuesday, Homeland ... of air passengers from Guinea, Liberia and Sierra ... airports -- New York City,s Kennedy International Airport, ...
(Date:10/22/2014)... The Louis W. Sullivan Institute ... distribute health information technology innovation to transform quality ... development of six key guiding principles of patient-centered ... These are an expansion of the Institute of ... is respectful of and responsive to individual patient ...
(Date:10/22/2014)... 22, 2014 With the Affordable Care Act ... by the American Institutes for Research (AIR) finds that three ... use health insurance, but 42 percent say they are not ... before signing up for coverage. , The AIR survey found ... percent able to calculate correctly how much they owe for ...
(Date:10/22/2014)... 22, 2014 Best Cheap Hosting USA ... world. The site has recently announced that iPower ( ... for people from around the world. , “iPower is ... today and is providing various kinds of useful products ... insists on offering excellent customer service and a number ...
(Date:10/22/2014)... (PRWEB) October 22, 2014 Losing Weight Your ... industry is staring you in the face, it certainly can ... not do your body an extra favor by doing it ... tempting crash diets. Instead, listen to your body, exercise regularly, ... Exercise is essential to losing weight; you need to exercise ...
Breaking Medicine News(10 mins):Health News:Passengers From Ebola-Affected Countries Must Land at Designated U.S. Airports 2Health News:Passengers From Ebola-Affected Countries Must Land at Designated U.S. Airports 3Health News:The Sullivan Institute for Healthcare Innovation Announces Release of Guiding Principles for Patient Experience-Centered Care 2Health News:Many Americans Fail to Ask Basic Questions Before Signing Up for Health Insurance, National Survey Finds 2Health News:Many Americans Fail to Ask Basic Questions Before Signing Up for Health Insurance, National Survey Finds 3Health News:Many Americans Fail to Ask Basic Questions Before Signing Up for Health Insurance, National Survey Finds 4Health News:Best Cheap Hosting USA Has Recently Announced The Best Cheap Web Hosting Companies In 2014 2Health News:ReductionGuruMD Presents Ways to Improve Your Weight Loss Results 2
... COLUMBUS, Ohio Researchers have identified when an important ... knowledge to new situations. In a series of ... newly acquired knowledge in a different circumstance, but 16-month-olds ... 16 months, infants begin learning how to learn," said ...
... altered metabolisms, which may help them generate the energy they ... reporting in the July Cell Metabolism , a Cell ... even before detectable tumors form. By the same token, the ... tumor metabolism shifts back before established tumors shrink. ...
... Ergonomics Society invites you to attend the 2012 Symposium ... be held March 12-14, 2012, at the Marriott Baltimore ... this exciting first-time event. The symposium aims to ... scientific and practice realms of the health-care community and ...
... Goodwin HealthDay Reporter , MONDAY, July 4 ... may play a larger role than shared genes in ... suggests. A second study in the same journal ... environmental trigger. In the first study, researchers from ...
... in people who have never smoked show greater genome ... lung cancer in never smokers arises through different pathways, ... on Lung Cancer in Amsterdam, hosted by the International ... "We identified several genomic regions that were differentially altered ...
... important ingredients for long-term relationship satisfaction, according to an ... throughout committed relationships, but contrary to stereotypes, tenderness was ... Also contrary to expectations of the researchers, ... their relationship, while women were more likely to report ...
Cached Medicine News:Health News:Infants learn to transfer knowledge by 16 months, study finds 2Health News:Infants learn to transfer knowledge by 16 months, study finds 3Health News:Metabolic shift may offer early cancer clue 2Health News:HFES sponsors 2012 Symposium on Human Factors and Ergonomics in Health Care 2Health News:Environment May Be Especially Key to Autism: Study 2Health News:Environment May Be Especially Key to Autism: Study 3Health News:Environment May Be Especially Key to Autism: Study 4Health News:Lung tumors in never-smokers show greater genomic instability than those in smokers 2Health News:Couples report gender differences in relationship, sexual satisfaction over time 2Health News:Couples report gender differences in relationship, sexual satisfaction over time 3
(Date:10/22/2014)... Oct. 21, 2014  Early symptoms of diabetic ... unnoticed, but new technology, coupled with yearly, comprehensive ... to earlier detection of eye diseases, including those ... Americans. If left untreated, these diseases can potentially ... Recently, optometric researchers have deployed a ...
(Date:10/22/2014)... 2014   Surefire Medical , Inc., the developer ... maximize targeted delivery of embolization agents in minimally invasive ... John R. Daniels , MD of the University ... oncologist Steven C. Katz , MD of the ... Advisory Board (SAB).    "The role of ...
(Date:10/22/2014)... 22, 2014 WHEN: Wednesday, October 29, 2014 ... available at: http://bit.ly/1yStiU9 SPEAKERS: Visionary ... Visionary Innovation Research Group Senior Research Analyst ... materials, nanobots and flexible electronics are among ... our lives in the coming decades. These ...
Breaking Medicine Technology:Technology Advancements Enhance Early Detection of Eye Diseases Associated with Diabetes 2Technology Advancements Enhance Early Detection of Eye Diseases Associated with Diabetes 3Surefire Medical's Scientific Advisory Board Expands, Broadens Clinical Trial Expertise 2Futuristic Technologies That Will Transform Our World Beyond 2030 2Futuristic Technologies That Will Transform Our World Beyond 2030 3Futuristic Technologies That Will Transform Our World Beyond 2030 4
... Internal Pipeline as DARA Program Enters ... SARM Program is Added, PRINCETON, N.J., Nov. 1 ... and nine months ended,September 30, 2007, and highlighted several ... since the beginning,of the quarter. During the third ...
... Calif., Nov. 1 IDM Pharma, Inc.,(Nasdaq: IDMI ... the Phase 3 mifamurtide (L-MTP-PE) clinical trial (INT-0133). The,trial ... cooperative,group study conducted by the Children,s Oncology Group (COG) ... patients originally treated in the Phase,3 trial. The results ...
Cached Medicine Technology:Pharmacopeia Announces Third Quarter 2007 Financial Results 2Pharmacopeia Announces Third Quarter 2007 Financial Results 3Pharmacopeia Announces Third Quarter 2007 Financial Results 4Pharmacopeia Announces Third Quarter 2007 Financial Results 5Pharmacopeia Announces Third Quarter 2007 Financial Results 6Pharmacopeia Announces Third Quarter 2007 Financial Results 7Pharmacopeia Announces Third Quarter 2007 Financial Results 8Pharmacopeia Announces Third Quarter 2007 Financial Results 9Pharmacopeia Announces Third Quarter 2007 Financial Results 10Pharmacopeia Announces Third Quarter 2007 Financial Results 11IDM Pharma Announces Updated Phase 3 Mifamurtide (L-MTP-PE) Data Confirms Statistically Superior Overall Survival in Osteosarcoma Patients 2IDM Pharma Announces Updated Phase 3 Mifamurtide (L-MTP-PE) Data Confirms Statistically Superior Overall Survival in Osteosarcoma Patients 3IDM Pharma Announces Updated Phase 3 Mifamurtide (L-MTP-PE) Data Confirms Statistically Superior Overall Survival in Osteosarcoma Patients 4IDM Pharma Announces Updated Phase 3 Mifamurtide (L-MTP-PE) Data Confirms Statistically Superior Overall Survival in Osteosarcoma Patients 5IDM Pharma Announces Updated Phase 3 Mifamurtide (L-MTP-PE) Data Confirms Statistically Superior Overall Survival in Osteosarcoma Patients 6
... M2 is a dual-monochromator, multi-detection microplate ... and 6-384 microplate reading capability. Detection ... fluorescence intensity (FI) and have optical ... spectrofluorometer or spectrophotometer. Endpoint, kinetic, spectrum ...
... for Ultra High Throughput Screening (UHTS), ... detection performance. Allows for smooth transfer ... development by sharing all the detection ... fluorescence intensity, fluorescence polarization, time-resolved fluorescence, ...
... RUBYstar enables highly sensitive time-resolved fluorescence ... cryptate fluorophores. These compounds are excited ... long fluorescence lifetimes (several hundred microseconds), ... peak profiles at 620 nm. Therefore ...
... SAFIRE is the worlds first monochromator-based ... flexibility for absorbance and fluorescence application needs, ... , , Effortless selection of wavelengths without ... your chosen wavelength from the pull down ...
Medicine Products: